Stocks and Investing Stocks and Investing
Wed, May 4, 2022
Tue, May 3, 2022

Matthew O"Brien Maintained (ZBH) at Hold with Increased Target to $130 on, May 3rd, 2022


Published on 2024-10-27 20:49:01 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Increased Target from $110 to $130 on, May 3rd, 2022.

Matthew has made no other calls on ZBH in the last 4 months.

There are 15 other peers that have a rating on ZBH. Out of the 15 peers that are also analyzing ZBH, 9 agree with Matthew"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Joanne Wuensch of "Citigroup" Downgraded from Strong Buy to Hold and Increased Target to $129 on, Friday, April 1st, 2022
Jason Wittes of "Loop Capital" Downgraded from Strong Buy to Hold and Held Target at $130 on, Wednesday, March 2nd, 2022
Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $125 on, Tuesday, February 8th, 2022
Pito Chickering of "Deutsche Bank" Maintained at Hold with Decreased Target to $121 on, Tuesday, February 8th, 2022
Shagun Singh of "RBC Capital" Maintained at Hold with Decreased Target to $125 on, Tuesday, February 8th, 2022
Matthew Taylor of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $130 on, Wednesday, February 2nd, 2022
Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 10th, 2022
Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
Matt O"Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022

These are the ratings of the 6 analyists that currently disagree with Matthew;

Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Tuesday, February 8th, 2022
David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $145 on, Tuesday, February 8th, 2022
Lawrence Biegelsen of "Wells Fargo" Maintained at Sell with Decreased Target to $111 on, Tuesday, February 8th, 2022
Mike Matson of "Needham" Maintained at Strong Buy with Decreased Target to $143 on, Tuesday, February 8th, 2022
Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $128 on, Tuesday, February 8th, 2022
Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $124 on, Wednesday, January 19th, 2022

Contributing Sources